Overview
Astrid Kiermaier practices practicing medicine in Basel, Switzerland.
Her clinical expertise encompasses Breast Cancer, Gastroesophageal Junction Cancer, and PIK3CA-Related Overgrowth Spectrum.
She is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Astrid Kiermaier
Is Astrid Kiermaier a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Astrid Kiermaier is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Astrid Kiermaier participate in research or clinical trials?
Yes. Astrid Kiermaier has published 16 articles and abstracts on conditions like Breast Cancer. You can view a list of Astrid Kiermaier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMs. Kiermaier isExperienced. Learn about Breast Cancer.
- Gastroesophageal Junction CancerMs. Kiermaier isExperienced. Learn about Gastroesophageal Junction Cancer.
- PIK3CA-Related Overgrowth SpectrumMs. Kiermaier isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.